Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Short term Debt (2022 - 2025)

Trinity Biotech's Short term Debt history spans 4 years, with the latest figure at $1.1 million for Q2 2025.

  • On a quarterly basis, Short term Debt fell 22.85% to $1.1 million in Q2 2025 year-over-year; TTM through Jun 2025 was $1.1 million, a 22.85% decrease, with the full-year FY2024 number at $1.7 million, up 215.21% from a year prior.
  • Short term Debt hit $1.1 million in Q2 2025 for Trinity Biotech, down from $1.7 million in the prior quarter.
  • Over the last five years, Short term Debt for TRIB hit a ceiling of $2.0 million in Q2 2022 and a floor of $526000.0 in Q4 2023.
  • Historically, Short term Debt has averaged $1.3 million across 4 years, with a median of $1.4 million in 2024.
  • Biggest five-year swings in Short term Debt: soared 215.21% in 2024 and later dropped 22.85% in 2025.
  • Tracing TRIB's Short term Debt over 4 years: stood at $2.0 million in 2022, then plummeted by 73.73% to $526000.0 in 2023, then soared by 215.21% to $1.7 million in 2024, then plummeted by 32.81% to $1.1 million in 2025.
  • Business Quant data shows Short term Debt for TRIB at $1.1 million in Q2 2025, $1.7 million in Q4 2024, and $1.4 million in Q2 2024.